As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Immune Design, a filing with the SEC revealed that on Tuesday, Director Lewis W. Coleman purchased 40,000 shares of IMDZ, at a cost of $6.25 each, for a total investment of $250,000. Coleman was up about 22.2% on the purchase at the high point of today's trading session, with IMDZ trading as high as $7.63 in trading on Thursday. Immune Design is trading up about 0.5% on the day Thursday.
And at Ambac Financial Group, there was insider buying on Tuesday, by Chief Executive Officer Tavakoli Nader who bought 12,000 shares at a cost of $18.06 each, for a trade totaling $216,753. Before this latest buy, Nader purchased AMBC at 8 other times during the past twelve months, for a total cost of $3.35M at an average of $14.66 per share. Ambac Financial Group is trading up about 1.1% on the day Thursday. So far Nader is in the green, up about 5.1% on their buy based on today's trading high of $18.98.
For MarketNewsVideo.com, I'm Sayoko Murase.